Bank Of New York Mellon Corp Cure Vac N.V. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $1.36 Million - $2.01 Million	-103,549 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$14.73 - $35.25 $33,672 - $80,581	2,286 Added 2.26%	103,549 $2.03 Million
Q4 2021 Feb 11, 2022	BUY	$33.72 - $48.22 $625,067 - $893,854	18,537 Added 22.41%	101,263 $3.47 Million
Q3 2021 Nov 12, 2021	BUY	$49.26 - $74.5 $506,392 - $765,860	10,280 Added 14.19%	82,726 $4.52 Million
Q2 2021 Aug 11, 2021	BUY	$56.91 - $127.53 $4.12 Million - $9.24 Million	72,446 New	72,446 $5.32 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.